Foot and Mouth Disease (FMD) Vaccine - Global Market Trajectory & Analytics

Global Foot and Mouth Disease (FMD) Vaccine Market to Reach $3.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Foot and Mouth Disease (FMD) Vaccine estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027. Conventional Vaccines, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Emergency Vaccines segment is readjusted to a revised 7.6% CAGR for the next 7-year period.





The U.S. Market is Estimated at $537.5 Million, While China is Forecast to Grow at 10.4% CAGR

The Foot and Mouth Disease (FMD) Vaccine market in the U.S. is estimated at US$537.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$686.3 Million by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 42 Featured):

• Agrovet Co
• Beohringer Ingelheim
• Biogénesis Bagó
• Brilliant Bio Pharma Ltd.
• Ceva Santé Animale
• Empresa Colombiana de Productos Veterinarios S.A. VECOL S.A.
• FMD Center
• Godrej Agrovet Limited
• Indian Immunologicals Limited
• Limor de Colombia
• Merck Animal Health
• Merial S. A. S.
• Vecol SA
• Vetal Animal Health Products
• Veterinary Serum and Vaccine Research Institute